In summary, the downregulated NLRP3 gene in patients with early jSpA/ErA might reflect the occurrence of a subclinical inflammation of the gut mucosa (“low-grade IBD”), leading to a leaky gut (Figure 2). This evidence concerns the gene NLRP3 and inflammatory bowel disease.